A 49-year-old woman presents with 3 months of symmetrical pain and swelling in the metacarpophalangeal and proximal interphalangeal joints, morning stiffness lasting more than 1 hour, and elevated inflammatory markers. Rheumatoid factor and anti-CCP antibodies are positive. According to current rheumatoid arthritis management principles, what is the most appropriate initial disease-modifying therapy?